𝛼SK or Search

ENTITY

Sionna Therapeutics (SION US)

8

Analysis

Health Care • United States

Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.

more

Refresh

Exchange Announcement • 15 Sep 2026 04:10

Current Report (Form 8-K | Period ending 2026-09-09)

Exchange Announcement • 10 Aug 2026 19:15

Current Report (Form 8-K | Period ending 2026-08-10)

Exchange Announcement • 06 Aug 2026 19:19

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 19:12

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 19 Jun 2026 04:05

Current Report (Form 8-K | Period ending 2026-06-17)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x